In addition, the risks core correlated with the HCC immune cell markers, including IL10, ITGAM, STAT5B, CD68, HLA-DPB1, KIR2DL4, IRF5, CSF1R, CD274, HLA-DRA, CD8B, STAT1, NOS2, ITGAX, CD86, CD8A, BCL6, TGFB1, CD163, CCR8, TBX21, CCL2, CD3E, TNF, CD1C, CD2, HAVCR2, NRP1, STAT5A, CD3D, LAG3, HLA-DPA1, PDCD1, VSIG4, STAT3, GZMB, MS4A4A, GATA3, IFNG, and HLA-DQB1. The gene discussed is CD163; the disease is hepatocellular carcinoma.